N-H Lin|S Gronthos|P M Bartold - JoVE Visualize

Showing results (201-210 of 210) with videos related to

Pageof 21

Sort By:

You have reached the last page of results.This site can display upto 210 results.

Bioorganic & Medicinal Chemistry Letters|January 1, 1999

Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonistN H Lin, D E Gunn, Y Li, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterizationA W Bannon, M W Decker, P Curzon, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeysM W Decker, A W Bannon, P Curzon, et al.

Bioorganic & Medicinal Chemistry Letters|October 6, 1999

Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether frameworkN H Lin, M A Abreo, D E Gunn, et al.

Journal of Medicinal Chemistry|February 16, 1996

Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptorsM A Abreo, N H Lin, D S Garvey, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.

Journal of Medicinal Chemistry|January 31, 1997

Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.

Journal of Medicinal Chemistry|March 4, 1998

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptorsM W Holladay, J T Wasicak, N H Lin, et al.

Journal of Environmental Monitoring : JEM|October 31, 2007

Direct assessment of international consistency of standards for ground-level ozone: strategy and implementation toward metrological traceability network in AsiaH Tanimoto, H Mukai, Y Sawa, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in miceM W Holladay, H Bai, Y Li, et al.

Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:

Pageof 21

You have reached the last page of results.This site can display upto 210 results.

Bioorganic & Medicinal Chemistry Letters|January 1, 1999

Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonistN H Lin, D E Gunn, Y Li, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterizationA W Bannon, M W Decker, P Curzon, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeysM W Decker, A W Bannon, P Curzon, et al.

Bioorganic & Medicinal Chemistry Letters|October 6, 1999

Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether frameworkN H Lin, M A Abreo, D E Gunn, et al.

Journal of Medicinal Chemistry|February 16, 1996

Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptorsM A Abreo, N H Lin, D S Garvey, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.

Journal of Medicinal Chemistry|January 31, 1997

Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.

Journal of Medicinal Chemistry|March 4, 1998

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptorsM W Holladay, J T Wasicak, N H Lin, et al.

Journal of Environmental Monitoring : JEM|October 31, 2007

Direct assessment of international consistency of standards for ground-level ozone: strategy and implementation toward metrological traceability network in AsiaH Tanimoto, H Mukai, Y Sawa, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in miceM W Holladay, H Bai, Y Li, et al.

Pageof 21